A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FIRST-IN-HUMAN STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND IMMUNOGENICITY OF SINGLE DOSES OF LCA-0061 IN ATOPIC HEALTHY PARTICIPANTS AND MULTIPLE DOSES OF LCA-0061 IN PARTICIPANTS WITH PEANUT ALLERGY

Registry ID

LCA-0061-01

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

LYCIA THERAPEUTICS INC.

Start date

2026-08-11

Last update

2026-06-12

Conditions

• IGE-MEDIATED FOOD ALLERGY

Related clinical trials

• PHASE 2B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF RPT904 AS MONOTHERAPY IN PARTICIPANTS WITH IGE-MEDIATED FOOD ALLERGY

View on source registry